|
Company:
|
VERONA PHARMA PLC (VRNA)
|
|
Form Type:
|
F-6EF
|
|
Filing Date:
|
3/7/2023
|
|
CIK:
|
0001657312
|
|
Address:
|
3 MORE LONDON RIVERSIDE
|
|
City, State, Zip:
|
LONDON, SE1 2RE
|
|
Telephone:
|
011-44-0-2032834200
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$21.78
|
Change:
0.32 (1.49%)
|
Trade Time:
10:03 AM EST
|
Market Cap:
$13.84B
|
|
|
|
|
|
|
Description of Business
|
|
We were incorporated in February 2005 under the laws of England and Wales with
the Registrar of Companies of England and Wales under the name Isis Resources
plc. In September 2006, we acquired Rhinopharma Limited, a private company
incorporated in Canada, and changed our name to Verona Pharma plc. Our principal
office is located at 3 More London Riverside, London SE1 2RE, United Kingdom,
and our telephone number is +(44) 203 283 4200. The principal legislation under
which we operate is the Companies Act 2006.
Our agent for service of process in the United States is Cogency Global Inc.,
whose address is 10 E. 40th Street, 10th floor, New York, New York 10016.
Our principal capital expenditures for the year ended December 31, 2019 were
£0.3 million (2018: £0.3 million, 2017: £0.2 million). These capital
expenditures primarily consisted of patent costs.
|
|
|
|